0.2845
0.39%
+0.0011
Qualigen Therapeutics Inc Borsa (QLGN) Ultime notizie
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
GlobeNewswire Inc.
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
GlobeNewswire Inc.
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
GlobeNewswire Inc.
Capitalizzazione:
|
Volume (24 ore):